Robert Huben
Impact in
-
- Cancer Genomics and Diagnostics
-
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Prostate Cancer Diagnosis and Treatment 6
- Renal cell carcinoma treatment 4
- Prostate Cancer Treatment and Research 3
- Medical Imaging and Pathology Studies 1
-
- Renal and related cancers 3
- Co-authors
- Nachimuthu Natarajan (2 shared papers)Curtis Mettlin (2 shared papers)George R. Prout (3 shared papers)Avery A. Sandberg (3 shared papers)Mitsuaki A. Yoshida (2 shared papers)Kazuma Ohyashiki (2 shared papers)Hisako Ochi (2 shared papers)Zenon Gibas (2 shared papers)
- Journals
- Urology (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Journal of Immunotherapy (1 paper)The Journal of Urology (1 paper)The Prostate (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Robert Huben
12 papers receiving 484 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 149
- Pulmonary and Respiratory Medicine 298
- Reproductive Medicine 32
- Oncology 95
- Psychiatry and Mental health 50
Countries citing papers authored by Robert Huben
This map shows the geographic impact of Robert Huben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Huben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Huben more than expected).
Fields of papers citing papers by Robert Huben
This network shows the impact of papers produced by Robert Huben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Huben. The network helps show where Robert Huben may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Huben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. | 1986 | 148 |
| 2 | 1990 | 97 | |
| 3 | 1982 | 44 | |
| 4 | Initial clinical trial of the macrophage activator muramyl tripeptide-phosphatidylethanolamine encapsulated in liposomes in patients with advanced cancer. | 1990 | 43 |
| 5 | 1989 | 41 | |
| 6 | 1986 | 35 | |
| 7 | 2007 | 33 | |
| 8 | 1986 | 22 | |
| 9 | 1992 | 15 | |
| 10 | 1997 | 13 | |
| 11 | 1989 | 13 | |
| 12 | 1987 | 2 |
About Robert Huben
Robert Huben is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Immunology and Psychiatry and Mental health, having authored 12 papers that have together received 506 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (6 papers), Renal cell carcinoma treatment (4 papers), Cancer Genomics and Diagnostics (3 papers), Prostate Cancer Treatment and Research (3 papers), Renal and related cancers (3 papers), Sexual function and dysfunction studies (2 papers), Urologic and reproductive health conditions (1 paper) and Medical Imaging and Pathology Studies (1 paper). The work is most often cited by research in Cancer Research (149 citations), Pulmonary and Respiratory Medicine (298 citations), Reproductive Medicine (32 citations), Oncology (95 citations) and Psychiatry and Mental health (50 citations). Robert Huben has collaborated with scholars based in United States and China. Frequent co-authors include Nachimuthu Natarajan, Curtis Mettlin, George R. Prout, Avery A. Sandberg, Mitsuaki A. Yoshida, Kazuma Ohyashiki, Hisako Ochi, Zenon Gibas, J. Edson Pontes and J. Edson Pontes. Their work appears in journals such as Urology, International Journal of Radiation Oncology*Biology*Physics, Journal of Immunotherapy, The Journal of Urology and The Prostate.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.